Subscribe To
Comparing dcbs in de novo cad: drugs, design matter
At TCT 2023, two studies of sirolimus- vs paclitaxel-coated devices reached different conclusions about...
October 25, 2023, 10:16 pm
Aim immunotech announces report of complete topline data from roswell park comprehensive cancer center study evaluating ampligen® as a component of a chemokine-modulating (ckm) regimen, with paclitaxe
The post AIM ImmunoTech Announces Report of Complete Topline Data from Roswell Park Comprehensive Cancer Center Study Evaluating Ampligen® as a Compo...
September 11, 2023, 5:00 pm
Aim immunotech announces report of complete topline data from roswell park comprehensive cancer center study evaluating ampligen® as a component of a chemokine-modulating (ckm) regimen, with paclitaxe
The post AIM ImmunoTech Announces Report of Complete Topline Data from Roswell Park Comprehensive Cancer Center Study Evaluating Ampligen® as a Compo...
September 11, 2023, 5:00 pm
Novocure shares plunge after ovarian cancer study failure
Shares of Novocure Ltd. NVCR, -0.77% dropped 37% premarket on Monday after the Swiss oncology company said a late-stage trial of Tumor Treating Fields...
August 28, 2023, 8:34 am
Oncolytics: proof of concept in 2 large market indications
Positive results achieved, in using pelareorep + paclitaxel for the treatment of HR+/HER2- metastatic b...
July 3, 2023, 5:39 pm
paclitaxel injection market to grow at a cagr of -3.4% from 2023 to 2031, reaching us$ 484.5 million: as per tmr study
Increasing awareness and screening programs is a major factor that is anticipated to escalate the paclitaxel...
June 16, 2023, 8:30 pm
What to expect from fulgent genetics in 2023
We initiate our coverage of Fulgent Genetics with an "outperform" rating and a $42 target price for the next 12 months. The company is continuing its ...
May 14, 2023, 1:47 am
Why is athenex (atnx) stock up 44% today?
Athenex (NASDAQ: ATNX ) stock is rocketing higher on Tuesday thanks to positive results from a high-risk early-stage breast cancer clinical trial. The...
December 20, 2022, 12:24 pm